This Government Contract opportunity from Department Of Defense was posted on May 10, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Pharmaceutical Product Supply – Paxlovid Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract involves the supply of FDA-approved Nirmatrelvir and Ritonavir tablets, commercially known as Paxlovid, specifically packaged in blister packs. These pharmaceutical products must comply with stringent Department of Defense (DoD), Defense Logistics Agency (DLA), and military medical standards, ensuring appropriate quality, adequate shelf life, and proper packaging configurations suitable for military distribution and usage. The procurement is managed by the Medical Supply Chain Pharmacy Field Supply Activity under the Department of Defense, with the place of performance designated as FPO, ZIP code 96694-1500. The solicitation for this subcontract was posted on May 10, 2026, with responses due by May 18, 2026, indicating a relatively short turnaround for proposals. It falls under the NAICS code 325411, which covers pharmaceutical preparation manufacturing. Although specific details such as the solicitation number and point of contact are not provided, the contract is accessible through the Department of Defense’s electronic bidding system. This effort underscores the military’s ongoing initiative to maintain a reliable supply of key antiviral treatments aligned with federal standards to support force readiness and healthcare capabilities.
General Info
Agency
NAICS
Place of Performance
FPO, AP, 96694-1500, USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
